Showing results (61-70 of 126) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancyGlenn Liu, Jordan Berlin, Kendra D Tutsch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 13, 2011
Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105Hao Hong, Gregory W Severin, Yunan Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumorsGlenn Liu, Jill Kolesar, Douglas G McNeel, et al.
Clinical Genitourinary Cancer|October 19, 2015
A Phase II Study of AT-101 to Overcome Bcl-2--Mediated Resistance to Androgen Deprivation Therapy in Patients With Newly Diagnosed Castration-Sensitive Metastatic Prostate CancerMark N Stein, Maha Hussain, Walter M Stadler, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2015
Pharmacodynamic study of axitinib in patients with advanced malignancies assessed with (18)F-3'deoxy-3'fluoro-L-thymidine positron emission tomography/computed tomographyJustine Yang Bruce, Peter Colin Scully, Lakeesha L Carmichael, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled PembrolizumabChristopher G England, Emily B Ehlerding, Reinier Hernandez, et al.
Cancer|June 10, 2011
Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrenceTim J Kruser, David F Jarrard, Andrew K Graf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2014
Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancerDouglas G McNeel, Jordan T Becker, Jens C Eickhoff, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2011
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinomaJoshua M Lang, Mahazarin R Kaikobad, Marianne Wallace, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2011
Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malateGlenn Liu, Robert Jeraj, Matt Vanderhoek, et al.
Pageof 13